Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747888 · ClinicalTrials.gov registry record · NA
Hereditary Risk Factors for Thyroid Cancer
A NA study of Thyroid Cancer, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT02747888 is a NA study of Thyroid Cancer that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 250 participants, roughly in line with the 276-participant average among 46 other Thyroid Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT02747888, a NA study of Thyroid Cancer, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at risk for developing thyroid cancer and thyroid nodules. * In this study, family and medical history information is collected alongside a blood or saliva sample for genetic studies. * Individuals with a past or present childhood thyroid cancer/nodule or a thyroid cancer suspected to be inherited in their family are invited to participate.
Conditions Studied
Interventions
- GENETIC •Referral to Genetic Counselor, if indicated
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2029-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02747888
The ClinicalTrials.gov registry entry for NCT02747888 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 276-participant average among 46 other Thyroid Cancer trials with a reported enrollment target. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thyroid Cancer appearing as the primary indexed condition, and to 1 intervention - of which •Referral to Genetic Counselor, if indicated is the first listed.
NCT02747888 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02747888 about?
NCT02747888 is a clinical study titled "Hereditary Risk Factors for Thyroid Cancer". Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at ...
What is the current status of trial NCT02747888?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2016-03-01. Estimated completion is 2029-03-01.
What conditions does trial NCT02747888 study?
This clinical trial studies the following conditions: Thyroid Cancer.
What interventions are being tested in trial NCT02747888?
The interventions under investigation include: •Referral to Genetic Counselor, if indicated (GENETIC).
Who is sponsoring clinical trial NCT02747888?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02747888 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
TRAIL Study: Feasibility and Pilot
RECRUITING · NA
-
Personalized Treatment in Thyroid Disorders
RECRUITING · NA
-
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
RECRUITING · NA
-
Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery
RECRUITING · NA
-
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.